Inositol metabolism in Trypanosoma cruzi: Potential target for chemotherapy against Chagas' disease

Anais da Academia Brasileira de Ciencias

Volumn 72, Issue 3, 2000, Pages 413-419

  Oliveira, Mecia M ^b   Einicker Lamas, Marcelo ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE

Author keywords

Chagas' disease; Chemotherapy; Inositol; Trypanosoma cruzi

Indexed keywords

INOSITOL;

ANIMAL; CHAGAS DISEASE; HUMAN; LIPID METABOLISM; METABOLISM; REVIEW; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; HUMANS; INOSITOL; LIPID METABOLISM; TRYPANOSOMA CRUZI;

EID: 0034267634     PISSN: 00013765     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0001-37652000000300015     Document Type: Article

References (38)

1. ALMEIDA IC, FERGUSON MAJ, SCHENKMAN S & TRAVASSOS LR. 1994. Lytic anti α-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem J 304: 793-802.
2. ANTUNES A & OLIVEIRA MM. 1981. Phospholipid metabolism in Trypanosoma cruzi-I. phosphate moiety turnover. Comp Biochem Physiol 70: 327-330.
3. BARRETT MP, TETAUD E, SEYFANG A, BRINGAUD F & BALTZ T. 1998. Trypanosome glucose transporters. Mol Biochem Parasitol 91: 195-205.
4. BERRIDGE MJ. 1984. Inositol trisphosphate and diacylglycerol as second messengers. Biochem J 220: 345-360.
5. BRENER Z & GAZZINELLI RT. 1997. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol 114: 103-110.
6. CARREIRA JC, JONES C, WAIT R, PREVIATO JO & MENDONÇA-PREVIATO L. 1996. Structural variations in the glycoinositolphospholipids of different strains of Trypanosoma cruzi. Glycoconj J 13: 955-966.
7. +)ATPase activity. Z Naturf 53C: 1049-1054.
8. +-ATPase activity in Trypanosoma cruzi epimastigotes. Z Naturf 54C: 100-104.
9. CHAGAS, C. 1909. Nova tripanosomíase humana. Estudos sobre a morfologia e o ciclo evolutivo de Schizotrypanum cruzi n. gen., n. sp., agente etiológico de nova entidade mórbida do homem. Mem Inst Oswaldo Cruz 1: 159-219.
10. COSULICH SC, OFFER JL, SMITH GA, HESKETH R & METCALFE JC. 1993. Effects of fluorinated inositols on the proliferation of Swiss 3T3 fibroblasts. Biochem J 292: 719-724.
11. DE CASTRO SL. 1993. The challenge of Chagas Disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi. Acta Trop 53: 83-98.
12. DEL CASTILLO M, MENDOZA G, OVIEDO J, PEREZ BIANCO RP, ANSELMO AE & SILVA M. 1990. AIDS and Chagas' disease with central nervous system tumor-like lesion. Am J Med 88(6): 693-694.
13. DOCAMPO R & PIGNATARO OP. 1991. The inositol phosphate/diacylglycerol signalling pathway in Trypanosoma cruzi. Biochem J 194: 2-7.
14. + symporter from Leishmania donovani. Mol Cell Biol 15: 5508-5515.
15. EAGLE H, OYAMA VI, LEVY M & FREEMAN AE. 1957. myo-inositol as an essential growth factor for normal and malignant human cells in tissue culture. J Biol Chem 248: 191-205.
16. EINICKER-LAMAS M, MALAQUIAS AT, DE CASTRO SL, SMITH GA & OLIVEIRA MM. 1999. Effects of fluorinated inositols on the phosphoinositides metabolism and the proliferation of Trypanosoma cruzi. Parasitol Res 85: 232-238.
17. EINICKER-LAMAS M, ALMEIDA AC, TODOROV AG, DE CASTRO SL, CARUSO-NEVES C & OLIVEIRA MM. 2000. Characterization of myo-inositol transport system in Trypanosoma cruzi. Eur J Biochem 267: 1-6.
18. FERGUSON MAJ. 1999. The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. J Cell Science 112: 2799-2809.
19. FERGUSON MAJ, BRIMACOMBE JS, BROWN JS, CROSSMAN A, DIX A, FIELD RA, GUTHER MLS, MILNE KG, SHARMA DK & SMITH TK. 1999. The GPI biosynthetic pathway as a therapeutic target for African sleeping sickness. Biochim Biophys Acta 1455: 327-340.
20. HOLUB BJ. 1982. Advances in nutritional research. In: DRAPER HH ed., p. 107, Plenum Press NY.
21. KANEDA Y, NAGAKURA K & GOUTSU T. 1986. Lipid composition of three morphological stages of Trypanosoma cruzi. Comp Biochem Physiol 83B: 533-536.
22. KOZIKOWSKI AP, FAUQ AH, POWIS G & MELDER DC. 1990. Efficient synthetic routes to fluorinated isosteres of inositol and their effects on cellular growth. J Am Chem Soc 112: 4528-4531.
23. LEDERKREMER RM, LIMA C, RAMIREZ ML, FERGUSON MAJ, HOMANS SW & THOMAS-OATHS JE. 1991. Complete structure of the glycan of lipopeptidophosphoglycan from Trypanosoma cruzi epimastigotes. J Biol Chem 266: 23670-23675.
24. MACHADO DE DOMENECH EE, GARCIA M, GARRIDO MN & RACAGNI G. 1992. Phospholipids of Trypanosoma cruzi: increase of polyphosphoinositides and phosphatidic acid after cholinergic stimulation. FEMS Microbiol Lett 74: 267-270.
25. MALAQUIAS AT & OLIVEIRA MM. 1999. Phospholipid signalling in Trypanosoma cruzi growth control. Acta Trop 73: 93-108.
26. MCPHEE F, DOWNES CP & LOWE G. 1991. Studies of inositol analogues as inhibitors of the phosphoinositide pathway, and incorporation of 2-deoxy-2-fluoro-myo-inositol to give analogues of phosphatidylinositol intermediates. Biochem J 277: 407-412.
27. MOVER JD, REIZES O, AHIR S, JIANG C, MALINOWISKY N & BAKER DC. 1988. Substrate properties of analogs of myo-inositol. Mol Pharmacol 33: 683-689.
28. NISHIZUKA Y. 1984. Turnover of inositol phospholipids and signal transduction. Science 225: 1365-1370.
29. 3H-labelled monodeoxyfluoro-myo-inositols into thymocytes and their incorporation into phospholipid in permeabilized cells. Biochem J 291: 553-560.
30. OLIVEIRA MM, ROCHA ED, RONDINELLI E, ARNHOLDT AV & SCHARFSTEIN J. 1993. Signal transduction in Trypanosoma cruzi: opposite effects of adenylcyclase and phospholipase C systems in growth control. Mol Cell Biochem 124: 91-99.
31. PREVIATO JO, GORIN PAJ, MAZUREK MT, FOURNET B, WIERUSZESK JM & MENDONÇA-PREVIATO L. 1990. Primary structure of the oligosaccharide chain of lipopeptidophosphoglycan of epimastigote forms of Trypanosoma cruzi. J Biol Chem 265: 2528-2526.
32. PREVIATO JO, JONES C, XAVIER MT, WAIT R, TRAVASSOS LR & MENDONÇA-PREVIATO L. 1995. Structural characterisation of the major glycosylphosphatidylinositol membrane anchored glycoprotein from epimastigote forms of Trypanosoma cruzi. J Biol Chem 270: 7241-7250.
33. 2+ mobilization and microfilament rearrangement in host cells. J Cell Biol 129: 1263-1273.
34. RODRIGUEZ JB & GROSS EG. 1995. Recent developments in the control of Trypanosoma cruzi, the causative agent for Chagas' disease. Curr Med Chein 2: 723-742.
35. SCHMUNIS GA, ZICKER F & MONCAYO A. 1996. Interruption of Chagas disease transmission through vector elimination. The Lancet 348: 1171.
36. SERRANO AA, SCHENKMAN S, YOSHIDA N, MEHLERT A, RICHARDSON JM & FERGUSON MAJ. 1995. The lipid structure of the GPI-anchored mucin-like sialic acid acceptors of Trypanosoma cruzi changes during parasite differentiation from epimastigotes to infective metacyclic trypomastigote forms. J Biol Chem 270: 27244-27253.
37. TODOROV AG, EINICKER-LAMAS M, DE CASTRO SL, OLIVEIRA MM & GUILHERME AL. 2000. Activation of host cell class I p85/p110 and class II C2α phosphatidylinositol-3-kinase by Trypanosoma cruzi infection. J Biol Chem in press.
38. TOKER A & CANTLEY LC. 1997. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387: 673-676.